Comparison

VX-765 European Partner

Item no. TMO-T6298-25mg
Manufacturer TargetMol
CASRN 851091-96-8
Amount 25 mg
Quantity options 1 mL x 10 mM (in DMSO) 10 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles CCOC1OC(=O)CC1NC(=O)C1CCCN1C(=O)C(N C(=O)C1=CC(Cl)=C(N)C=C1)C(C)(C)C
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias VX-765,Belnacasan,IL-1 inhibitor;Caspase inhibitor
Similar products 851091-96-8
Shipping Condition Cool pack
Available
Shipping Temperature
Cool Pack
Storage Conditions
-20°C
Description
VX-765, an orally active IL-converting enzyme/caspase-1 inhibitor, blocked IL-1beta secretion with equal potency in LPS-stimulated cells from FCAS and control subjects.
Formulate
C24H33ClN4O6

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close